Versuchen GOLD - Frei

Can Med Tourism Industry Hit Goldmine With Robot-Assisted Surgery?

BioSpectrum Asia

|

BioSpectrum Asia March 2023

The quality of Healthcare is projected to become enhanced in the future, aided by new innovations in technology.

Can Med Tourism Industry Hit Goldmine With Robot-Assisted Surgery?

Robot-assisted surgery (RAS) has seen significant advancement of late, bringing the promise of much better surgical and post surgical success rates. In the medical device industry, surgical robots are one of the fastest growing sectors. In addition to providing superior mobility, robotic surgery devices allow surgeons to reach confined spaces and provide extremely advanced imaging capabilities, with better dexterity. Yet, the robotic surgery industry is struggling to thrive in most developing countries. Let’s discover the reasons behind.

When compared with conventional laparoscopic and endoscopic techniques, robotic surgery allows intricate and advanced surgical procedures to be performed more precisely and with minimal skin incision.

To achieve maximum precision impact, robotassisted surgery platforms utilise electrosurgical hardware, instruments, artificial intelligence and data analytics. The robotic surgery minimises tissue damage, pain, and hospital readmissions as it is able to be implanted precisely during the surgery. In addition, with the 3-dimensional visualisation of image (rather than 2-dimensional vision in standard laparoscopy) surgical robotics further eliminates the risk of hand tremors. Advanced models offer voice-activated or manual master controls for demonstrating steady camera motion in addition to ergonomic design and training simulator. Despite the benefits of minimally invasive surgery (MIS), shorter hospital stays, and faster return to normal activities, only about 3 per cent of surgeries are performed robotically in the world.

Technological advancements have even enabled effective remote surgeries by demonstrating the tremendous potential of robotic aids and 5G technology. Surgeons and traumatologists are equitably empowered by the surgical robots technologies.

WEITERE GESCHICHTEN VON BioSpectrum Asia

BioSpectrum Asia

BioSpectrum Asia

India signs MoU with Pfizer to strengthen healthcare innovation ecosystem

In a significant step towards strengthening India's healthcare innovation ecosystem, the Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, Government of India, has signed a Memorandum of Understanding (MoU) with US-based Pfizer Limited.

time to read

1 min

BioSpectrum Asia Oct 2025

BioSpectrum Asia

BioSpectrum Asia

New Zealand to lead new gene therapy trial for muscular dystrophy

The first clinical trial of a new treatment for a rare form of muscular dystrophy is being led by New Zealand-based University of Auckland's Centre for Brain Research.

time to read

1 min

BioSpectrum Asia Oct 2025

BioSpectrum Asia

BioSpectrum Asia

Scientists in Australia grow living skin in world-first

Australia's University of Queensland (UQ) researchers have been the first in the world to successfully grow fully functioning human skin in a laboratory.

time to read

1 min

BioSpectrum Asia Oct 2025

BioSpectrum Asia

BioSpectrum Asia

India joins Health AI Global Regulatory Network to strengthen oversight of AI in healthcare

HealthAI - The Global Agency for Responsible AI in Health, has welcomed India as a pioneer country joining the HealthAI Global Regulatory Network (GRN), a global network of health regulators dedicated to the safe and effective use of artificial intelligence (AI) in healthcare.

time to read

1 min

BioSpectrum Asia Oct 2025

BioSpectrum Asia

BioSpectrum Asia

TVM Capital Healthcare announces first closing of $150 M Southeast Asia Fund

Singapore-based TVM Capital Healthcare, a global private equity investor and operator specialised in healthcare growth capital across emerging markets, has announced the first closing of its $150 million TVM Healthcare Southeast Asia Fund (SEA Fund).

time to read

1 min

BioSpectrum Asia Oct 2025

BioSpectrum Asia

BioSpectrum Asia

National Yang Ming Chiao Tung University, TSH Biopharm collaborate to foster pharma talent in Taiwan

Taiwan's National Yang Ming Chiao Tung University (NYCU) and TSH Biopharm have signed a five-year industry-academia collaboration Memorandum of Understanding (MOU).

time to read

1 min

BioSpectrum Asia Oct 2025

BioSpectrum Asia

BioSpectrum Asia

Fujifilm Biosciences introduces BalanCD HEK293 Perfusion A Medium

Fujifilm Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the life science market, has announced the commercial launch of BalanCD HEK293 Perfusion A.

time to read

1 min

BioSpectrum Asia Oct 2025

BioSpectrum Asia

BioSpectrum Asia

Korea makes smart patch that can run tests using sweat instead of blood

A research team at Korea Advanced Institute of Science and Technology has developed a smart patch that can precisely observe internal changes through sweat when simply attached to the body.

time to read

1 min

BioSpectrum Asia Oct 2025

BioSpectrum Asia

BioSpectrum Asia

ADB approves $106.9 M to strengthen secondary healthcare services in Sri Lanka

The Asian Development Bank (ADB) has approved a $106.9 million financing package to strengthen Sri Lanka's secondary curative care services, improve communicable disease prevention and control, and enhance the healthcare sector's governance and management capacity.

time to read

1 min

BioSpectrum Asia Oct 2025

BioSpectrum Asia

BioSpectrum Asia

Epigenic Therapeutics raises $60 M to accelerate clinical development of medicines

China-based startup Epigenic Therapeutics, a clinical-stage innovative drug development company, has announced the completion of a $60 million Series B round of financing led by Lapam Capital, with continued participation from existing investors Qiming Venture Partners and OrbiMed, and addition of new investors including IFSC and a renowned investment firm in the industry.

time to read

1 min

BioSpectrum Asia Oct 2025

Translate

Share

-
+

Change font size